{
  "id": 20589626,
  "title": "Mild Alzheimer's patients benefit from 40Hz sensory stimulation in national clinical trial",
  "url": "https://urgent.news/2026/11/18/mild-alzheimers-patients-benefit-from-40hz-sensory-stimulation-in",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-18T11:20:02.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-11-mild-alzheimer-patients-benefit-40hz.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "At the Clinical Trials on Alzheimer's Disease conference in Boston Nov. 16, MIT spinoff company Cognito Therapeutics announced the results of its pivotal clinical trial of a noninvasive, device-based approach to Alzheimer's disease (AD) treatment first discovered in The Picower Institute in 2014. The \"HOPE\" trial included 663 people in two \"prespecified\" subgroups of volunteers: those with…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}